{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:17:34Z","timestamp":1792279054626,"version":"4.4.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuron"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.neuron.2022.11.012","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T10:33:49Z","timestamp":1670582029000},"page":"508-525.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Excessive proteostasis contributes to pathology in fragile X syndrome"],"prefix":"10.1016","volume":"111","author":[{"given":"Susana R.","family":"Louros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang S.","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4258-9354","authenticated-orcid":false,"given":"Beatriz","family":"Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Martinez-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Gonzalez-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melania","family":"Muscas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick C.","family":"Verity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimi C.","family":"Wills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Wan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew F.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0582-2284","authenticated-orcid":false,"given":"Emily K.","family":"Osterweil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuron.2022.11.012_bib32","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1038\/s41467-022-30979-0","article-title":"Excess ribosomal protein production unbalances translation in a model of Fragile X Syndrome","volume":"13","author":"Seo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuron.2022.11.012_bib1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7692601","article-title":"FMR1 protein: conserved RNP family domains and selective RNA binding","volume":"262","author":"Ashley","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.neuron.2022.11.012_bib2","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1542\/peds.2013-4301","article-title":"Fragile X syndrome: a review of associated medical problems","volume":"134","author":"Kidd","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuron.2022.11.012_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0092-8674(93)90420-U","article-title":"The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein","volume":"74","author":"Siomi","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2022.11.012_bib4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(91)90397-H","article-title":"Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome","volume":"65","author":"Verkerk","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2022.11.012_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5582\/irdr.2014.01022","article-title":"Fragile X spectrum disorders","volume":"3","author":"Lozano","year":"2014","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.neuron.2022.11.012_bib6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1542\/peds.2008-0317","article-title":"Advances in the treatment of fragile X syndrome","volume":"123","author":"Hagerman","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuron.2022.11.012_bib7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuron.2015.06.017","article-title":"Altered neuronal and circuit excitability in fragile X syndrome","volume":"87","author":"Contractor","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.11.012_bib8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.neubiorev.2016.06.033","article-title":"Hippocampal dysfunction and cognitive impairment in Fragile-X Syndrome","volume":"68","author":"Bostrom","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuron.2022.11.012_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-neuro-060909-153138","article-title":"The pathophysiology of fragile X (and what it teaches us about synapses)","volume":"35","author":"Bhakar","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib10","doi-asserted-by":"crossref","first-page":"15616","DOI":"10.1523\/JNEUROSCI.3888-10.2010","article-title":"Hypersensitivity to mGluR5 and ERK1\/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome","volume":"30","author":"Osterweil","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/nn.2175","article-title":"Excess protein synthesis in Drosophila fragile X mutants impairs long-term memory","volume":"11","author":"Bolduc","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.npp.1301610","article-title":"Fragile X: translation in action","volume":"33","author":"Bear","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2022.11.012_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nrn4001","article-title":"Dysregulation and restoration of translational homeostasis in fragile X syndrome","volume":"16","author":"Richter","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib14","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/ajmg.a.36241","article-title":"Fragile X syndrome: From protein function to therapy","volume":"161A","author":"Bagni","year":"2013","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuron.2022.11.012_bib15","series-title":"Fragile X Syndrome: From Genetics to Targeted Treatment R","article-title":"The mGluR Theory From Mice to Men","author":"Stoppel","year":"2017"},{"key":"10.1016\/j.neuron.2022.11.012_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2012.03.009","article-title":"Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice","volume":"74","author":"Michalon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.11.012_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuron.2012.01.034","article-title":"Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome","volume":"77","author":"Osterweil","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.11.012_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.celrep.2015.03.060","article-title":"Increased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome","volume":"11","author":"Gross","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuron.2022.11.012_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/hmg\/10.4.329","article-title":"Evidence that fragile X mental retardation protein is a negative regulator of translation","volume":"10","author":"Laggerbauer","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2022.11.012_bib20","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/nar\/29.11.2276","article-title":"The fragile X mental retardation protein inhibits translation via interacting with mRNA","volume":"29","author":"Li","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuron.2022.11.012_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1097-2765(00)80012-X","article-title":"FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association","volume":"1","author":"Feng","year":"1997","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuron.2022.11.012_bib22","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1093\/hmg\/11.24.3007","article-title":"Trapping of messenger RNA by Fragile X Mental Retardation protein into cytoplasmic granules induces translation repression","volume":"11","author":"Mazroui","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2022.11.012_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2022.11.012_bib24","doi-asserted-by":"crossref","first-page":"e46919","DOI":"10.7554\/eLife.46919","article-title":"FMRP has a cell-type-specific role in CA1 pyramidal neurons to regulate autism-related transcripts and circadian memory","volume":"8","author":"Sawicka","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.neuron.2022.11.012_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0092-8674(01)00568-2","article-title":"Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome","volume":"107","author":"Brown","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2022.11.012_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0092-8674(03)00079-5","article-title":"The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses","volume":"112","author":"Zalfa","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2022.11.012_bib27","doi-asserted-by":"crossref","first-page":"15201","DOI":"10.1073\/pnas.0404995101","article-title":"The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development","volume":"101","author":"Lu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2022.11.012_bib28","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1523\/JNEUROSCI.4650-11.2012","article-title":"Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered Arc translation and long-term depression","volume":"32","author":"Niere","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.neuron.2017.07.013","article-title":"Cell-Type-Specific Translation Profiling Reveals a Novel Strategy for Treating Fragile X Syndrome","volume":"95","author":"Thomson","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.11.012_bib30","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/j.celrep.2019.02.086","article-title":"Widespread alterations in translation elongation in the brain of juvenile Fmr1 knockout mice","volume":"26","author":"Das Sharma","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuron.2022.11.012_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fnmol.2017.00340","article-title":"Cell type-specific mRNA dysregulation in hippocampal CA1 pyramidal neurons of the fragile X syndrome mouse model","volume":"10","author":"Ceolin","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib33","doi-asserted-by":"crossref","first-page":"E4697","DOI":"10.1073\/pnas.1502258112","article-title":"Fmr1 deficiency promotes age-dependent alterations in the cortical synaptic proteome","volume":"112","author":"Tang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2022.11.012_bib34","doi-asserted-by":"crossref","first-page":"25479","DOI":"10.1074\/jbc.M109.042663","article-title":"Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities","volume":"284","author":"Sch\u00fctt","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2022.11.012_bib35","doi-asserted-by":"crossref","first-page":"25495","DOI":"10.1074\/jbc.M110.210260","article-title":"Proteomics, ultrastructure, and physiology of hippocampal synapses in a fragile X syndrome mouse model reveal presynaptic phenotype","volume":"286","author":"Klemmer","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2022.11.012_bib36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.12688\/f1000research.10599.1","article-title":"Recent insights on principles of synaptic protein degradation","volume":"6","author":"Cohen","year":"2017","journal-title":"F1000Res."},{"key":"10.1016\/j.neuron.2022.11.012_bib37","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature04769","article-title":"Activity-dependent dynamics and sequestration of proteasomes in dendritic spines","volume":"441","author":"Bingol","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2022.11.012_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nn1013","article-title":"Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system","volume":"6","author":"Ehlers","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib39","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2012.04.031","article-title":"Activity-dependent growth of new dendritic spines is regulated by the proteasome","volume":"74","author":"Hamilton","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.11.012_bib40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1101\/lm.1504010","article-title":"The ubiquitin-proteasome pathway and synaptic plasticity","volume":"17","author":"Hegde","year":"2010","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuron.2022.11.012_bib41","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuron.2010.11.006","article-title":"Deconstruction for reconstruction: the role of proteolysis in neural plasticity and disease","volume":"69","author":"Bingol","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.11.012_bib42","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0076-6879(05)98030-0","article-title":"Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates","volume":"398","author":"Kisselev","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.neuron.2022.11.012_bib43","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2017.04.023","article-title":"The Logic of the 26S Proteasome","volume":"169","author":"Collins","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2022.11.012_bib44","first-page":"115","article-title":"CaMKII, but not protein kinase A, regulates Rpt6 phosphorylation and proteasome activity during the formation of long-term memories","volume":"7","author":"Jarome","year":"2013","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biochi.2015.02.006","article-title":"Ubiquitination of newly synthesized proteins at the ribosome","volume":"114","author":"Wang","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.neuron.2022.11.012_bib46","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35008096","article-title":"Rapid degradation of a large fraction of newly synthesized proteins by proteasomes","volume":"404","author":"Schubert","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2022.11.012_bib47","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1126\/science.289.5487.2117","article-title":"Detecting and measuring cotranslational protein degradation in\u00a0vivo","volume":"289","author":"Turner","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuron.2022.11.012_bib48","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","article-title":"Correction of fragile X syndrome in mice","volume":"56","author":"D\u00f6len","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2022.11.012_bib49","doi-asserted-by":"crossref","first-page":"eaao0498","DOI":"10.1126\/scitranslmed.aao0498","article-title":"Sustained correction of associative learning deficits after brief, early treatment in a rat model of Fragile X Syndrome","volume":"11","author":"Asiminas","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2022.11.012_bib50","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1523\/JNEUROSCI.2915-10.2011","article-title":"Dual regulation of fragile X mental retardation protein by group I metabotropic glutamate receptors controls translation-dependent epileptogenesis in the hippocampus","volume":"31","author":"Zhao","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib51","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.celrep.2015.02.020","article-title":"Coordination between translation and degradation regulates inducibility of mGluR-LTD","volume":"10","author":"Klein","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuron.2022.11.012_bib52","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1152\/physrev.00003.2005","article-title":"Mammalian G proteins and their cell type specific functions","volume":"85","author":"Wettschureck","year":"2005","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuron.2022.11.012_bib53","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/pr.117.015370","article-title":"A Practical review of proteasome pharmacology","volume":"71","author":"Thibaudeau","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuron.2022.11.012_bib54","doi-asserted-by":"crossref","first-page":"60656","DOI":"10.18632\/oncotarget.19269","article-title":"Emerging drugs and combinations to treat multiple myeloma","volume":"8","author":"Larocca","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuron.2022.11.012_bib55","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.15252\/embj.201593594","article-title":"The effects of proteasomal inhibition on synaptic proteostasis","volume":"35","author":"Hakim","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.neuron.2022.11.012_bib56","doi-asserted-by":"crossref","first-page":"e52714","DOI":"10.7554\/eLife.52714","article-title":"The switch-like expression of heme-regulated kinase 1 mediates neuronal proteostasis following proteasome inhibition","volume":"9","author":"Alvarez-Castelao","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.neuron.2022.11.012_bib57","doi-asserted-by":"crossref","first-page":"e52939","DOI":"10.7554\/eLife.52939","article-title":"Proteome dynamics during homeostatic scaling in cultured neurons","volume":"9","author":"D\u00f6rrbaum","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.neuron.2022.11.012_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbamcr.2013.08.012","article-title":"Regulation of proteasome activity in health and disease","volume":"1843","author":"Schmidt","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuron.2022.11.012_bib59","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.1158\/0008-5472.CAN-07-0568","article-title":"Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.neuron.2022.11.012_bib60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature09299","article-title":"Enhancement of proteasome activity by a small-molecule inhibitor of USP14","volume":"467","author":"Lee","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2022.11.012_bib61","doi-asserted-by":"crossref","first-page":"19209","DOI":"10.1074\/jbc.M117.815126","article-title":"An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons","volume":"292","author":"Boselli","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2022.11.012_bib62","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1601-183X.2004.00087.x","article-title":"A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse","volume":"3","author":"Yan","year":"2004","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuron.2022.11.012_bib63","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.neuropharm.2005.06.004","article-title":"Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP","volume":"49","author":"Yan","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuron.2022.11.012_bib64","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ajmg.1320380276","article-title":"Epilepsy and fragile X syndrome: a follow-up study","volume":"38","author":"Musumeci","year":"1991","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuron.2022.11.012_bib65","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1469-8749.2002.tb00277.x","article-title":"Epilepsy in fragile X syndrome","volume":"44","author":"Berry-Kravis","year":"2002","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neuron.2022.11.012_bib66","doi-asserted-by":"crossref","first-page":"720752","DOI":"10.3389\/fpsyt.2021.720752","article-title":"Neural correlates of auditory hypersensitivity in fragile X syndrome","volume":"12","author":"Razak","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuron.2022.11.012_bib67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13229-017-0140-1","article-title":"Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome","volume":"8","author":"Ethridge","year":"2017","journal-title":"Mol. Autism."},{"key":"10.1016\/j.neuron.2022.11.012_bib68","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004703-200112000-00008","article-title":"The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders","volume":"22","author":"Rogers","year":"2001","journal-title":"J.\u00a0Dev. Behav. Pediatr."},{"key":"10.1016\/j.neuron.2022.11.012_bib69","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.0.CO;2-K","article-title":"Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report","volume":"83","author":"Miller","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuron.2022.11.012_bib70","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1097\/00001756-200108080-00056","article-title":"Auditory evoked magnetic fields in adults with fragile X syndrome","volume":"12","author":"Rojas","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuron.2022.11.012_bib71","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1152\/jn.00706.2019","article-title":"Abnormal development of auditory responses in the inferior colliculus of a mouse model of Fragile X Syndrome","volume":"123","author":"Nguyen","year":"2020","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuron.2022.11.012_bib72","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1523\/JNEUROSCI.0886-19.2019","article-title":"Audiogenic seizures in the Fmr1 knock-out mouse are induced by Fmr1 deletion in subcortical, VGlut2-expressing excitatory neurons and require deletion in the inferior colliculus","volume":"39","author":"Gonzalez","year":"2019","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biopsycho.2015.06.016","article-title":"Stimulus-specific adaptation in the inferior colliculus: The role of excitatory, inhibitory and modulatory inputs","volume":"116","author":"Ayala","year":"2016","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.neuron.2022.11.012_bib74","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1475-2867-5-18","article-title":"Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy","volume":"5","author":"Boccadoro","year":"2005","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.neuron.2022.11.012_bib75","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.nbd.2016.01.008","article-title":"CNS uptake of bortezomib is enhanced by P-glycoprotein inhibition: implications for spinal muscular atrophy","volume":"88","author":"Foran","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2022.11.012_bib76","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/exnr.1999.7047","article-title":"Differential roles in the neuronal network for audiogenic seizures are observed among the inferior colliculus subnuclei and the amygdala","volume":"157","author":"Chakravarty","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuron.2022.11.012_bib77","series-title":"Neuronal Networks in Brain Function, CNS Disorders, and Therapeutics","first-page":"349","article-title":"Neuronal networks in epilepsy: comparative audiogenic seizure networks","author":"Faingold","year":"2014"},{"key":"10.1016\/j.neuron.2022.11.012_bib78","doi-asserted-by":"crossref","first-page":"104722","DOI":"10.1016\/j.neubiorev.2022.104722","article-title":"Translational validity and methodological underreporting in animal research: A systematic review and meta-analysis of the Fragile X syndrome (Fmr1 KO) rodent model","volume":"139","author":"Kat","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuron.2022.11.012_bib79","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/mol.109.056127","article-title":"Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures","volume":"76","author":"Pacey","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuron.2022.11.012_bib80","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1021\/cn500077p","article-title":"Lithium: a promising treatment for fragile X syndrome","volume":"5","author":"Liu","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib81","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0097-19.2019","article-title":"Lovastatin, not Simvastatin, corrects core phenotypes in the fragile X mouse model","volume":"6","author":"Muscas","year":"2019","journal-title":"eNeuro"},{"key":"10.1016\/j.neuron.2022.11.012_bib82","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/aur.168","article-title":"Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses","volume":"4","author":"Spencer","year":"2011","journal-title":"Autism Res."},{"key":"10.1016\/j.neuron.2022.11.012_bib83","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.bbrc.2006.05.043","article-title":"Induction of 26S proteasome subunit PSMB5 by the bifunctional inducer 3-methylcholanthrene through the Nrf2-ARE, but not the AhR\/Arnt-XRE, pathway","volume":"345","author":"Kwak","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuron.2022.11.012_bib84","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.bbrc.2013.12.113","article-title":"Ameliorating replicative senescence of human bone marrow stromal cells by PSMB5 overexpression","volume":"443","author":"Lu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuron.2022.11.012_bib85","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2001681118","article-title":"Genetic removal of p70 S6K1 corrects coding sequence length-dependent alterations in mRNA translation in fragile X syndrome mice","volume":"118","author":"Aryal","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2022.11.012_bib86","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1016\/j.celrep.2020.02.076","article-title":"FMRP control of ribosome translocation promotes chromatin modifications and alternative splicing of neuronal genes linked to autism","volume":"30","author":"Shah","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuron.2022.11.012_bib87","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/nn.3379","article-title":"The translation of translational control by FMRP: therapeutic targets for FXS","volume":"16","author":"Darnell","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib88","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/(SICI)1097-4547(19980101)51:1<41::AID-JNR4>3.0.CO;2-L","article-title":"Overexpression of fragile X gene (FMR-1) transcripts increases cAMP production in neural cells","volume":"51","author":"Berry-Kravis","year":"1998","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuron.2022.11.012_bib89","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fnbeh.2016.00136","article-title":"Multiple drug treatments that increase cAMP signaling restore long-term memory and aberrant signaling in fragile X syndrome models","volume":"10","author":"Choi","year":"2016","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib90","doi-asserted-by":"crossref","first-page":"e931","DOI":"10.1371\/journal.pone.0000931","article-title":"The cyclic AMP cascade is altered in the fragile X nervous system","volume":"2","author":"Kelley","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.neuron.2022.11.012_bib91","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/s41591-021-01321-w","article-title":"Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial","volume":"27","author":"Berry-Kravis","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuron.2022.11.012_bib92","doi-asserted-by":"crossref","first-page":"152ra128","DOI":"10.1126\/scitranslmed.3004218","article-title":"Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen","volume":"4","author":"Henderson","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuron.2022.11.012_bib93","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/npp.2017.236","article-title":"R-baclofen reverses cognitive deficits and improves social interactions in two lines of 16p11.2 deletion mice","volume":"43","author":"Stoppel","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2022.11.012_bib94","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1152\/jn.90752.2008","article-title":"Imbalance of neocortical excitation and inhibition and altered UP states reflect network hyperexcitability in the mouse model of fragile X syndrome","volume":"100","author":"Gibson","year":"2008","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuron.2022.11.012_bib95","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1523\/JNEUROSCI.2251-20.2021","article-title":"The ubiquitinated axon: local control of axon development and function by ubiquitin","volume":"41","author":"Pinto","year":"2021","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib96","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/2040-2392-5-45","article-title":"Ubiquitin-proteasome dependent degradation of GABAAalpha1 in autism spectrum disorder","volume":"5","author":"Crider","year":"2014","journal-title":"Mol. Autism."},{"key":"10.1016\/j.neuron.2022.11.012_bib97","doi-asserted-by":"crossref","first-page":"9526","DOI":"10.1074\/jbc.M115.705004","article-title":"Grp94 protein delivers gamma-aminobutyric acid type A (GABAA) receptors to Hrd1 protein-mediated endoplasmic reticulum-associated degradation","volume":"291","author":"Di","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuron.2022.11.012_bib98","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1113\/JP271031","article-title":"Genetic upregulation of BK channel activity normalizes multiple synaptic and circuit defects in a mouse model of fragile X syndrome","volume":"594","author":"Deng","year":"2016","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuron.2022.11.012_bib99","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1523\/JNEUROSCI.1593-18.2018","article-title":"Voltage-independent SK-channel dysfunction causes neuronal hyperexcitability in the hippocampus of Fmr1 knock-out mice","volume":"39","author":"Deng","year":"2019","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2022.11.012_bib100","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/biomedicines10030647","article-title":"Disruption of the Ubiquitin-Proteasome System and Elevated Endoplasmic Reticulum Stress in Epilepsy","volume":"10","author":"Poliquin","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuron.2022.11.012_bib101","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1093\/hmg\/ddy189","article-title":"Loss of fragile X protein FMRP impairs homeostatic synaptic downscaling through tumor suppressor p53 and ubiquitin E3 ligase Nedd4-2","volume":"27","author":"Lee","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2022.11.012_bib102","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4161\/chan.5.1.13967","article-title":"Regulation of voltage-gated ion channels in excitable cells by the ubiquitin ligases Nedd4 and Nedd4-2","volume":"5","author":"Bongiorno","year":"2011","journal-title":"Channels"},{"key":"10.1016\/j.neuron.2022.11.012_bib103","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nrd.2017.221","article-title":"Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome","volume":"17","author":"Berry-Kravis","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuron.2022.11.012_bib104","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuroscience.2019.12.030","article-title":"Ubiquitination and E3 ubiquitin ligases in rare neurological diseases with comorbid epilepsy","volume":"428","author":"Zhu","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2022.11.012_bib105","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/jnc.13723","article-title":"Perturbed proteostasis in autism spectrum disorders","volume":"139","author":"Louros","year":"2016","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuron.2022.11.012_bib106","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0137-20.2020","article-title":"Ubiquitin and ubiquitin-like proteins in the critical equilibrium between synapse physiology and intellectual disability","volume":"7","author":"Folci","year":"2020","journal-title":"eNeuro"},{"key":"10.1016\/j.neuron.2022.11.012_bib107","doi-asserted-by":"crossref","first-page":"1700304","DOI":"10.1002\/pmic.201700304","article-title":"Comparative analyses of data independent acquisition mass spectrometric approaches: DIA, WiSIM-DIA, and untargeted DIA","volume":"18","author":"Koopmans","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.neuron.2022.11.012_bib108","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1021\/ac026117i","article-title":"Stop and go extraction tips for matrix-assisted laser desorption\/ionization, nanoelectrospray, and LC\/MS sample pretreatment in proteomics","volume":"75","author":"Rappsilber","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neuron.2022.11.012_bib109","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuron.2022.11.012_bib110","doi-asserted-by":"crossref","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","article-title":"UniProt: the universal protein knowledgebase in 2021","volume":"49","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuron.2022.11.012_bib111","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"Dennis","year":"2003","journal-title":"Genome Biol."}],"container-title":["Neuron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627322010352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627322010352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T07:41:52Z","timestamp":1760254912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896627322010352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0896627322010352"],"URL":"https:\/\/doi.org\/10.1016\/j.neuron.2022.11.012","relation":{},"ISSN":["0896-6273"],"issn-type":[{"value":"0896-6273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excessive proteostasis contributes to pathology in fragile X syndrome","name":"articletitle","label":"Article Title"},{"value":"Neuron","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuron.2022.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}